In its continuing war against copycat drugs, Eli Lilly (LLY) said on Wednesday that it filed suits against four telehealth companies that offer cheaper versions of its blockbuster GLP-1 weight loss drugs Mounjaro and Zepbound.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Eli Lilly is stepping up its fight against copycat weight-loss drugs )
Also on site :
- Drifting architects: Plankton, climate, and the race to understand our changing ocean
- Über das Spiel hinaus: Haier Vision für Jugend und Nachhaltigkeit
- The Three States Driving America’s Solar Boom